PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative disease…
Author: Business Wire
Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases
INGELHEIM, Germany and NEWTON, Mass.–(BUSINESS WIRE)–Boehringer Ingelheim and Inflammasome Therapeutics Inc. (Inflammasome) today announced they have entered into a co-development and license agreement to develop up to three therapies for patients wi…
Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases
INGELHEIM, Germany & NEWTON, Mass.–(BUSINESS WIRE)–Inflammasome and Boehringer Ingelheim Partners enter into co-development and license agreement for retinal disease therapies
Oyster Point Pharma Expands Executive Leadership Team
PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma announces the appointment of Dan Lochner, MBA as its Chief Financial Officer and John Snisarenko, MBA as Chief Commercial Officer.
Aerie Pharmaceuticals Submits Prior Approval Supplement to the U.S. Food and Drug Administration to Allow Production of Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in its Athlone Ireland Facility
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Compulink Launches E-Commerce Solution for its All-in-One Optometry EHR at Vision Expo West
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink launches e-commerce solution for its all-in-one Optometry EHR at Vision Expo West.
Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion
EnChroma Unveils New Kid’s Trial Kit and Color Blind Test for Kids
LAS VEGAS & BERKELEY, Calif.–(BUSINESS WIRE)– #colorishere–EnChroma announced the EnChroma® Kid’s Kit and a new kid-friendly color blind test for more easily testing children ages 5+ for color blindness.
IVERIC bio to Present at the Ladenburg Thalmann 2019 Healthcare Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that CMO Kourous A. Rezaei, MD, will present an overview of the Company at the Ladenburg Thalmann 2019 Healthcare Conference.
Alcon Prices US$2.0 Billion Senior Notes Offering
GENEVA–(BUSINESS WIRE)–Alcon prices US$2.0 billion senior notes offering
Alcon Prices US$2.0 Billion Senior Notes Offering
GENEVA–(BUSINESS WIRE)–Alcon prices US$2.0 billion senior notes offering
NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that Yenyou (Jeff) Zheng, Ph.D. has joined the Compan…
Genentech Presents New Six-year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today longer-term data from the Phase III open-label extension studies of OPERA I, OPERA II and ORATORIO showed that patients w…
L’Italie a déployé le système de dépistage oculaire basé sur l’IA EyeArt d’Eyenuk pour sa première campagne nationale de prévention et de diagnostic de la maculopathie rétinienne et diabétique
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., une société mondiale de technologies et services médicaux basés sur l’intelligence artificielle (IA), qui se démarque en tant que leader des applications en situation réelle pour AI Eye Screening™, a annoncé a…
Italien hat das EyeArt-AI-Eye-Screening-System von Eyenuk für die erste nationale Präventions- und Diagnosekampagne für retinale und diabetische Makulopathie eingesetzt
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., ein weltweit tätiges Unternehmen für Medizintechnik und Dienstleistungen im Bereich der künstlichen Intelligenz (KI) (englisch: Artificial Intelligence, AI) und Marktführer bei realen Anwendungen für AI-Eye-Sc…
Samenvatting: Italië zet EyeArt AI-oogscreeningssysteem Eyenuk in voor eerste nationale campagne ter preventie en diagnose van netvlies- en diabetische maculopathie
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., een wereldwijd bedrijf voor medische technologie en diensten op het gebied van kunstmatige intelligentie (AI) en de leider op het gebied van praktische toepassingen voor AI Eye Screening™, heeft aangekondigd d…
Resumen: Italia presenta EyeArt, el sistema de examen ocular por IA de Eyenuk, para la primera campaña nacional de prevención y diagnóstico de la degeneración macular retiniana y diabética
LOS ÁNGELES–(BUSINESS WIRE)–Eyenuk Inc., compañía global de servicios y tecnología médicos impulsados por inteligencia artificial (IA) y líder en aplicaciones del mundo real para AI Eye Screening™, ha anunciado hoy que el sistema de examen ocular Eye…
Riassunto: Adottato in Italia per la prima campagna nazionale di diagnosi e prevenzione della retinopatia e maculopatia diabetica il sistema di screening oculare basato sull’intelligenza artificiale EyeArt di Eyenuk
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., fornitore globale di tecnologie e servizi medici basati su intelligenza artificiale (artificial intelligence, AI) nonché leader nelle applicazioni nel mondo reale della tecnologia AI Eye Screening™, ha annunci…
Endospan Enters Into Strategic Distribution Agreement With CryoLife
HERZLIYA, Israel–(BUSINESS WIRE)–Endospan, a pioneer in off-the-shelf endovascular repair of aortic arch disease, today announced it has entered into strategic distribution and credit facility agreements with CryoLife, Inc. (NYSE: CRY), a leading car…
Italy Deployed Eyenuk’s EyeArt AI Eye Screening System for First National Retinal and Diabetic Maculopathy Prevention and Diagnosis Campaign
LOS ANGELES–(BUSINESS WIRE)–Eyenuk’s EyeArt® AI Eye System was deployed successfully for Italy’s first national prevention and diagnosis campaign for diabetic maculopathy.